Related Experiment Videos
Antibiotics in childhood pneumonia
Katherine A Hale1, David Isaacs
1Department of Allergy, The Children's Hospital at Westmead, Australia. katherh2@chw.edu.au
Paediatric Respiratory Reviews
|June 13, 2006
Summary
Pneumonia is a common childhood illness diagnosed using clinical, radiological, and lab methods. Streptococcus pneumoniae is a key cause, and treatment involves antibiotics targeting likely bacterial pathogens.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Pneumonia is a leading global cause of childhood illness.
- Diagnosis involves clinical judgment, radiology, and laboratory tests.
- Streptococcus pneumoniae is the primary bacterial cause of community-acquired pneumonia in children.
Purpose of the Study:
- To review the diagnosis and management of childhood pneumonia.
- To discuss common and emerging pathogens.
- To explore antibiotic strategies, resistance, and vaccination impacts.
Main Methods:
- Clinical assessment and diagnostic investigations (radiology, laboratory).
- Identification of common pathogens: Streptococcus pneumoniae, viruses (e.g., RSV), and atypical bacteria (Mycoplasma, Chlamydia).
- Review of antibiotic treatment principles and emerging concerns.
Main Results:
- Diagnosis often relies on clinical suspicion due to difficulties in pathogen isolation.
- Antibiotic therapy is guided by likely pathogens.
- Emerging pathogens, antibiotic resistance, and conjugate vaccines are critical considerations.
Conclusions:
- Effective management of childhood pneumonia requires a combination of diagnostic approaches and targeted antibiotic therapy.
- Understanding pathogen prevalence and resistance patterns is crucial for optimizing treatment.
- Pneumococcal conjugate vaccines play a significant role in prevention.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...